Article info
PDFOriginal research
Role of front-line bevacizumab in advanced ovarian cancer: the OSCAR study
- Correspondence to Dr Marcia Hall, Mount Vernon Cancer Centre, Northwood HA6 2RN, UK; marcia.hall{at}nhs.net
Citation
Role of front-line bevacizumab in advanced ovarian cancer: the OSCAR study
Online issue publication
February 25, 2020
Article Versions
- Previous version (6 February 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2020. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, an indication of whether changes were made, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.